ROLE OF LOS AND ITS RECEPTORS IN GONOCOCCAL PATHEGENEIS
Project Number5R01AI046613-02
Contact PI/Project LeaderINGALLS, ROBIN R
Awardee OrganizationBOSTON MEDICAL CENTER
Description
Abstract Text
Description (Adapted from the applicant's abstract): Neisseria gonorrhoeae is a
major cause of sexually transmitted diseases. While this organism primarily
infects the lower genital tract, it can ascend to the upper female genital
tract, and certain strains are capable of dissemination. Early events in the
establishment of infection involve interactions between N. gonorrhoeae and
cells present in the human genital tract. Here, surface antigens on the
gonococcus trigger the local and systemic humoral immune response that results
in the release of cytokines, prostaglandins, and other inflammatory mediators.
Previous efforts have focused on defining immunologic responses to protein
antigens on the surface of N. gonorrhoeae. In contrast, little attention has
been paid to the pro-inflammatory effects of the endotoxin lipopolysaccharide,
LPS) that coats the surface of all Gram-negative bacteria, including the
gonococcus. With Neisseria meningitidis, as well as most enteric Gram-negative
pathogens, it is clear that the acute cytokine response associated with the
sepsis syndrome is due, in a large part, to the interaction of LPS with its
receptors. For N. gonorrhoeae, however, the role of its endotoxin (also known
as lipooligosaccharide or LOS) their responsiveness to various strains of
gonococci and their LOSs. These in the activation of epithelial cells
encountered during mucosal infection of the genital tract are unproven,
although its pro-inflammatory activity in vitro has been documented.
The goal of this proposal is to characterize the role of gonococcal LOS in the
interaction between N. gonorrhoeae and the epithelial cells found in the female
genital tract. First, the PI will characterize three novel epithelial cell
lines derived from the female genital tract in terms of cell lines may
represent a new in vitro model for examining the pathogenesis of gonococcal
infections. Second, the PI will make two mutants in the lipid A component of
gonococcal LOS. Lipid A has been shown to be responsible for the
pro-inflammatory effects of LPS, and loss or modification of lipid A would be
expected to impact o the pathogenicity of a Gram-negative bacterium. Finally,
the PI will examine the role of epithelial cell receptors for endotoxin in
gonococcal invasion and activation, with an emphasis on Toll, a family of
receptors recently identified as components of the LPS signaling pathway.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
005492160
UEI
JZ8RQC4EMDZ5
Project Start Date
15-January-2000
Project End Date
31-December-2004
Budget Start Date
01-January-2001
Budget End Date
31-December-2001
Project Funding Information for 2001
Total Funding
$140,271
Direct Costs
$89,061
Indirect Costs
$51,210
Year
Funding IC
FY Total Cost by IC
2001
National Institute of Allergy and Infectious Diseases
$140,271
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI046613-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI046613-02
Patents
No Patents information available for 5R01AI046613-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI046613-02
Clinical Studies
No Clinical Studies information available for 5R01AI046613-02
News and More
Related News Releases
No news release information available for 5R01AI046613-02
History
No Historical information available for 5R01AI046613-02
Similar Projects
No Similar Projects information available for 5R01AI046613-02